{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T22:06:39Z","timestamp":1759961199852},"reference-count":6,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1097\/coc.0000000000000648","type":"journal-article","created":{"date-parts":[[2020,1,24]],"date-time":"2020-01-24T18:59:42Z","timestamp":1579892382000},"page":"146-147","source":"Crossref","is-referenced-by-count":2,"title":["Vincristine Shortage: What Other Options We Have?"],"prefix":"10.1097","volume":"43","author":[{"given":"Osama M.","family":"Al-Quteimat","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","published-online":{"date-parts":[[2020,1,23]]},"reference":[{"key":"R1-20230903","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1089\/jayao.2018.0041","article-title":"High-dose vincristine sulfate liposome injection, for advanced, relapsed, or refractory Philadelphia chromosome-negative acute lymphoblastic leukemia in an adolescent and young adult subgroup of a phase 2 clinical trial","volume":"7","author":"Schiller","year":"2018","journal-title":"J Adolesc Young Adult Oncol"},{"key":"R3-20230903","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1002\/pbc.25937","article-title":"Vincristine sulfate liposomes injection (VSLI, Marqibo\u00ae): results from a phase I study in children, adolescents, and young adults with refractory solid tumors or leukemias","volume":"63","author":"Shah","year":"2016","journal-title":"Pediatr Blood Cancer"},{"key":"R4-20230903","doi-asserted-by":"crossref","first-page":"e27694","DOI":"10.1002\/pbc.27694","article-title":"Effective and safe tumor inhibition using vinblastine in medulloblastoma","volume":"66","author":"Nobre","year":"2019","journal-title":"Pediatr Blood Cancer"},{"key":"R5-20230903","doi-asserted-by":"crossref","first-page":"581","DOI":"10.3109\/10428194.2011.621565","article-title":"Cyclophosphamide, doxorubicin, vincristine, prednisone and rituximab versus epirubicin, cyclophosphamide, vinblastine, prednisone and rituximab for the initial treatment of elderly \u201cfit\u201d patients with diff use large B-cell lymphoma: results from the ANZINTER3 trial of the Intergruppo Italiano Linfomi","volume":"53","author":"Merli","year":"2012","journal-title":"Leuk Lymphoma"},{"key":"R6-20230903","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/sj.leu.2404115","article-title":"High-dose imatinib mesylate combined with vincristine and dexamethasone (DIV regimen) as induction therapy in patients with resistant Philadelphia-positive acute lymphoblastic leukemia and lymphoid blast crisis of chronic myeloid leukemia","volume":"20","author":"Rea","year":"2006","journal-title":"Leukemia"},{"key":"R8-20230903","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1056\/NEJMoa1412096","article-title":"Bortezomib-based therapy for newly diagnosed mantle-cell lymphoma","volume":"372","author":"Robak","year":"2015","journal-title":"N Engl J Med"}],"container-title":["American Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/COC.0000000000000648","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,3]],"date-time":"2023-09-03T04:06:20Z","timestamp":1693713980000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/COC.0000000000000648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,23]]},"references-count":6,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020]]}},"URL":"https:\/\/doi.org\/10.1097\/coc.0000000000000648","relation":{},"ISSN":["0277-3732"],"issn-type":[{"value":"0277-3732","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1,23]]}}}